Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and tolerability of the dry powder
formulation of ASM-024 following single and multiple administration by inhalation of
ascending doses in healthy subjects and subjects with stable moderate asthma.